| Chronic Kidney Disease |
1 |
1 |
| Alzheimer Disease |
0 |
0.96 |
| Renal Failure |
0 |
0.78 |
| Geriatrics |
0 |
0.97 |
| Aducanumab |
0 |
0.99 |
| Aspirin |
0 |
0.98 |
| Dementia |
0 |
0.95 |
| Cerebrovascular Accident |
0 |
0.27 |
| Medicare |
0 |
0.16 |
| Mild Cognitive Impairment |
0 |
0.14 |
| Brain |
0 |
0.12 |
| Primary Care |
0 |
0.12 |
| Cognitive Impairment |
0 |
0.11 |
| Renal Disease |
0 |
0.11 |
| Gastrointestinal Hemorrhage |
0 |
0.1 |
| Positron Emission Tomography |
0 |
0.09 |
| Biologic Therapy |
0 |
0.08 |
| Cardiovascular disease |
0 |
0.08 |
| Cardiovascular Risk Management |
0 |
0.08 |
| Clinical Guidelines |
0 |
0.08 |
| Hemorrhage |
0 |
0.08 |
| Impairment |
0 |
0.08 |
| Internship |
0 |
0.08 |
| Kidney |
0 |
0.08 |
| Monoclonal Antibody |
0 |
0.08 |
| Healthcare and Medical Technology |
0 |
0.07 |
| Peptic Ulcer Disease |
0 |
0.07 |
| Adverse Effects |
0 |
0.04 |
| Amyloid Plaque |
0 |
0.04 |
| Anticoagulation Therapy |
0 |
0.04 |
| Anxiety |
0 |
0.04 |
| Anxiety Disorder |
0 |
0.04 |
| Cerebrospinal Fluid |
0 |
0.04 |
| Clinical Research |
0 |
0.04 |
| Corticosteroids |
0 |
0.04 |
| Disease-Modifying Therapy |
0 |
0.04 |
| Edema |
0 |
0.04 |
| Neuroendocrine Tumor |
0 |
0.04 |
| Neuroimaging |
0 |
0.04 |
| Nonsteroidal Anti-Inflammatory Agents |
0 |
0.04 |
| Nursing Homes |
0 |
0.04 |
| Pain Management |
0 |
0.04 |
| Patient Safety |
0 |
0.04 |
| Scan |
0 |
0.04 |
| Transient Ischemic Attack |
0 |
0.04 |
| Washington |
0 |
0.04 |
| Young Adult |
0 |
0.04 |